Correction to: Journal of Neurology https://doi.org/10.1007/s00415-019-09498-4
The original version of this article unfortunately contained a mistake. Fifth sentence of the fourth paragraph in the section “Non-nAChR autoantibody targets in MG” should read as
Cortactin is an intracellular protein involved in signaling downstream of MuSK, so, unlike Lrp4 and agrin, it is difficult to imagine how they might be pathogenic in vivo, without direct access to their intracellular targets.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chamberlain, J.L., Huda, S., Whittam, D.H. et al. Correction to: Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review. J Neurol 268, 1665 (2021). https://doi.org/10.1007/s00415-019-09568-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-019-09568-7